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Biofabrication of human articular cartilage: a path towards the development of a
clinical treatment
Abstract
Cartilage injuries cause pain and loss of function, and if severe may result in osteoarthritis (OA). 3D
bioprinting is now a tangible option for the delivery of bioscaffolds capable of regenerating the deficient
cartilage tissue. Our team has developed a handheld device, the Biopen, to allow in situ additive
manufacturing during surgery. Given its ability to extrude in a core/shell manner, the Biopen can preserve
cell viability during the biofabrication process, and it is currently the only biofabrication tool tested as a
surgical instrument in a sheep model using homologous stem cells. As a necessary step toward the
development of a clinically relevant protocol, we aimed to demonstrate that our handheld extrusion device
can successfully be used for the biofabrication of human cartilage. Therefore, this study is a required step
for the development of a surgical treatment in human patients. In this work we specifically used human
adipose derived mesenchymal stem cells (hADSCs), harvested from the infrapatellar fat pad of donor
patients affected by OA, to also prove that they can be utilized as the source of cells for the future clinical
application. With the Biopen, we generated bioscaffolds made of hADSCs laden in gelatin methacrylate,
hyaluronic acid methacrylate and cultured in the presence of chondrogenic stimuli for eight weeks in
vitro. A comprehensive characterisation including gene and protein expression analyses,
immunohistology, confocal microscopy, second harmonic generation, light sheet imaging, atomic force
mycroscopy and mechanical unconfined compression demonstrated that our strategy resulted in human
hyaline-like cartilage formation. Our in situ biofabrication approach represents an innovation with
important implications for customizing cartilage repair in patients with cartilage injuries and OA.
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ABSTRACT
Cartilage injuries cause pain and loss of function, and if severe may result in osteoarthritis.
3D bioprinting is now a tangible option for the delivery of bioscaffolds capable of regenerating
the deficient cartilage tissue. Our team has developed a handheld device, the Biopen, to allow
in situ additive manufacturing during surgery. Given its ability to extrude in a core/shell
manner, the Biopen can preserve cell viability during the biofabrication process, and it is
currently the only biofabrication tool tested as a surgical instrument in a sheep model using
homologous stem cells.
As a necessary step toward the development of a clinically relevant protocol, we aimed to
demonstrate that our handheld extrusion device can successfully be used for the biofabrication
of human cartilage. Therefore this study is a required step for the development of a surgical
treatment in human patients.
In this work we specifically used human derived mesenchymal stem cells (hADSCs), harvested
from the Infra-Patellar Fat Pad of donor patients affected by Osteoarthritis, to also prove that
they can be utilized as the source of cells for the future clinical application.
With the Biopen, we generated bioscaffolds made of hADSCs laden in Gelatin Methacrylate
(GelMa), hyaluronic acid methacrylate (HAMa) and cultured in the presence of chondrogenic
stimuli for eight weeks in vitro.
A comprehensive characterisation including gene and protein expression analyses,
immunohistology, confocal microscopy, second harmonic generation, light sheet imaging, and
mechanical unconfined compression demonstrated that our strategy resulted in human hyalinelike cartilage formation.
Our in situ biofabrication approach represents an innovation with important implications for
customizing cartilage repair in patients with cartilage injuries and osteoarthritis.

Keywords
Cartilage regeneration
Co-axial 3D extrusion
Biopen handheld extrusion device
GelMa/HAMa hydrogel
Adipose derived stem cells (hADSCs)
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1. Introduction
Hyaline cartilage tissue regeneration remains a challenge for musculoskeletal tissue
engineering. As a highly specialised tissue, it is characterised by low cell numbers, an avascular
aneural and aliphatic environment, a distinct three dimensional collagen fibre structure,
aggregated proteoglycans and matrix organisation [1]. All these characteristics confer specific
mechanical properties [2] [3], and make articular cartilage a challenging tissue to regenerate in
vitro and in vivo. Promising surgical treatments include Autologous Chondrocyte implantation
(ACI) and Matrix-induced Autologous Chondrocyte implantation (MACI) that some have
reported to be superior to self–repair inducing techniques such as microfractures [4] [5].
Nevertheless, MACI and ACI are multistage, complex procedures. These techniques require a
double operation: the surgical excision of native cartilage tissue and the expansion of adult
chondrocytes in vitro before implantation [5]. Previous studies have reported that 68% of
patients treated with the clinical product approved by the US Food and Drug Administration
(Carticel ®) had graft failure, delamination or tissue hypertrophy [6]. The major drawbacks
include the need for two operations, and that adult chondrocytes have the propensity to undergo
de-differentiation [7], thus losing the capability to produce hyaline cartilage extracellular
matrix and giving rise to reparative tissue that lacks durability [8] [9]. The lack of durability of
repaired cartilage leads to the development of osteoarthritis (OA) [10][11], which severely
limits the quality of life of affected individuals and represents one of the greatest contributors
to healthcare expenditure worldwide [12].
Regenerating healthy and long lasting articular hyaline-like cartilage is therefore considered a
key aim in musculoskeletal tissue engineering [13]. In this regard, mesenchymal stem cells
(MSCs) have been heralded as an appropriate candidate for cartilage repair owing to several
specific characteristics such as inherent chondrogenic property, ready availability, and cell
homing potential [14]. Despite these qualities, their use is still limited, with only 16% of
reported cell therapy procedures for cartilage repair registered at https://www.clinicaltrial.gov/
using MSCs [15].
3D bioprinting has added considerably to standard tissue engineering techniques, thanks to its
precision and control [16]. This promising technique can be applied to regenerate biological
tissues such as bone and cartilage [17][18]. A key challenge is now to bring cumbersome
bench-based technology to the operating room for real-time application.
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3D printing of scaffolds for chondral and osteochondral repair has been tried, using a
mosaicplasty-type technique, based on the implantation of scaffolds in defects that are premade in the laboratory before surgery [19][20][21][22]. 3D printing has the advantage of being
coupled with the use of “custom-designed” implants modelled on pre-operative MRI and/or
CT scans. For “custom designed” bench-based 3D printing techniques a highly detailed preoperative image of the cartilage defect needs to be obtained, so that the 3D printer can create
the desired bioscaffold to match the specific defect. Despite these strategies, however, a
mismatch between the bioscaffold and the host defect will likely remain because surgical
debridement before implantation alters the anatomy previously imaged, and even the most
advanced imaging techniques still fail to identify small gaps and defects. These issues
inevitably impede perfectly matching off-the-shelf and custom-designed prefabricated
bioscaffolds. The mechanical mismatch between implanted scaffolds and surrounding tissues
may inhibit cartilage regeneration at defect sites leading to implant failure [23]. In their
literature review, Mollon et al. summarized the limitations associated with current cartilage
repair techniques and noted that graft-site mismatch and size-depth mismatch were the most
frequent [24].
To tackle this challenge, as an alternative to computer aided 3D printing, we propose in situ
additive manufacturing. The advantages of in situ biofabrication for cartilage regeneration
include the possibility of perfectly match the defect geometry without specific preliminary
image analysis, shaping the bioscaffold within the defect and achieving the best possible
contact between the bioscaffold and the host tissue. In situ bioprinting has been proposed as a
valid option to deliver at the time and point of need a bioscaffold capable of regenerating
deficient tissue [25][26] and to limit the graft-site mismatch. Also a number of ex vivo
approaches have been proposed [27][28] to test the effective use of cell based therapies within
a defined defect, but to our knowledge our extrusion device, the Biopen [29], remains the only
hydrogel injection system that has been tested as a surgical instrument in a large animal model
of cartilage regeneration [30]. The Biopen is an advanced handheld co-axial extrusion device
that allows the deposition of cells embedded in a hydrogel material in the surgical setting.
Through this device, stem cell laden hydrogel scaffolds can be extruded in a co-axial core/shell
distribution, which favourably affects cell survival while maintaining adequate mechanical
properties for cartilage tissue engineering purposes. This result is achieved thanks to the
segregation of the cells in the core away from the photocrosslinking reaction confined to the
shell compartment [31].
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Our in vivo study was performed using allogenic ovine adipose derived stem cells [30]. To
progress towards translating our biofabrication tool into clinical practice, we aim to
demonstrate that the advantages of the Biopen are pivotal for the biofabrication of the human
cartilage. Therefore, this study is a required step in the development of a clinically relevant
protocol for the application of this biofabrication process in the clinical practice (Figure 1).

Figure 1. The path towards the development of a clinical treatment. The flow chart lists steps achieved (in
green) and the steps ahead (in red). The current study is indicated as the Neocartilage Biofabrication step and
represents the last in vitro analysis before the ex vivo and in vivo animal studies.

In our study we specifically used human derived mesenchymal stem cells (hADSCs), harvested
from the Infra-Patellar Fat Pad of donor patients affected by Osteoarthritis, envisioning them
as the source of cells for the future clinical application. We screened three different hADSCs
from three different patients to take in account also the inter-patient variability. Thus, for each
cell line we evaluated stemness and differentiation potential.
We used the Biopen to generate bioscaffolds in which hADSCs were laden in Gelatin
Methacrylate (GelMa) and hyaluronic acid methacrylate (HAMa) [29]. We cultured the
bioscaffolds in chondrogenic media for eight weeks and we analysed their ability to form
hyaline-like cartilage using molecular, imaging and mechanical analyses.
To our knowledge, we are the first to describe the capacity of a surgical device to biofabricate
in situ a regenerative stem cells niche. The impact of this technology has the potential to change
the clinical approaches in the surgical practice for the regeneration of tissues and organs.
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2. Materials and methods
2.1. Experimental design
Human stem cells were harvested and isolated from the infrapatellar fat pad of patients
undergoing total joint knee replacement. A

comprehensive profile analysis of

immunophenotypic characterization and evaluation of the differentiation potential was used to
assess the stemness of three different cell lines from three different donors to be used for the
bioprinting step. We then utilized the Biopen to biofabricate the scaffolds. To control the size
and shape of our samples, we used PDMS cylindrical moulds of 1 cm diameter and 1 mm
thickness with a total volume of approximately 80 l, so < 2 cm2, which is considered a critical
size defect in human cartilage injuries [32]. the limitations of the PDMS material, which is
more compliant and flexible than native cartilage, this bioprinting approach guarantees
reproducibility of structural organization and cell number, with suitable geometry for
mechanical testing, and was used for the entire set of experiments. We then extruded multiple
layers until the mould was filled to recreate a 3D structure.
After the photopolymerization reaction, we moved the samples to static culture conditions and
we cultivated the samples for 8 weeks in control or chondrogenic differentiation media. The
samples, three biological replicates [n = 3] for each of the three patients derived cell lines, were
collected and analysed every 4 weeks for a total of three time points. We then analysed the
capability of our biomanufactoring strategy to produce hyaline-like neocartilage. The cellular
response to the chondrogenic stimuli was determined by gene and protein expression analysis.
The building of new tissue was defined by protein localization and organization of the main
components of hyaline cartilage. The function of the neocartilage was then related to the
acquisition of mechanical properties over time (Figure 2).
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Figure 2. Graphical representation of the experimental plan and the corresponding time line. Three different cell
lines isolated from three patients were analysed in triplicate.

2.2. Synthesis of GelMa/HAMa
Gelatin-methacryloyl/hyaluronic acid methacryloyl (GelMa/HAMa) was synthesized as
previously described [31]. Briefly, the materials were dissolved to a final concentration of 100
mg ml−1 GelMa and 20 mg ml−1 HAMa (10% GelMa-2% HAMa) in sterile PBS (SigmaAldrich), containing 100 U ml−1 penicillin and 100 μg ml−1 of streptomycin (Gibco).
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2.3. Stem cells preparation
2.3.1. Stem cells isolation
Human Adipose Derived Stem cells (hADSCs) were isolated from human InfraPatellar Fat Pad
(IPFP) obtained intraoperatively from total knee arthroplasty with informed consent and
approval. Patients with mild/severe OA were recruited. A total of three patients were selected
for IPFP harvest. Use of all human samples and procedures in this study was approved by the
Human Research Ethics Committee Research Governance Unit of St. Vincent’s Hospital,
Melbourne, Australia [HREC/16/SVHM/186] and all the experiments were performed in
accordance with relevant guidelines and regulations.
hADSCs were isolated and expanded as previously described [33]. Briefly, the fat was diced
using a sterile scalpel and digested with 0.1% collagenase type I (Worthington Biochemical)
for 3 h at 37 °C under constant agitation, filtered through 100 m cell strainer nylon (BD
Falcon) and centrifuged at 400g at room temperature for 5 min to separate the stromal fraction
from the floating adipocytes. The supernatant was discarded and the cell pellet was
resuspended in Red Cell Lysis Buffer (160 mM NH4Cl; Sigma-Aldrich) and incubated at room
temperature for 10 min. The lysate was centrifuged at 400 g at room temperature for 5 min and
filtered through a 40 m nylon cell strainer (BD Falcon). The isolated cells were then plated in
monolayer culture and allowed to adhere for 48 h in culture media containing low glucose
DMEM (St.Louis, LA, USA) supplemented with 10% FBS (GIBCO, Thermo Fisher Scientific
Inc., Waltham, MA, USA), 100 U ml-1 Penicillin and 100 g ml-1 Streptomycin solution
(GIBCO), 2mM L-Glutamine (GIBCO), and 15 mM HEPES (GIBCO), 20 ng ml-1 epidermal
growth factor (EGF) and 1 ng ml-1 fibroblast growth factor (FGF) (R&D Systems Inc.,
Minneapolis, MN, USA). Non-adherent cells were then removed and the medium was replaced
with fresh medium. Cells were further cultivated and expanded for cell surface epitope
immunophenotypic characterization (flow cytometry) and multilineage differentiation.
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2.3.2. Stemness immunophenotypic characterization and differentiation potential
Immunophenotypic characterization of hADSCs was performed by fluorescence flow
cytometry analysis of cell-surface markers at passage 2 (P2). Cells were labelled with
monoclonal antibodies against CD14, CD31, CD34, CD45, CD73, CD90, CD106, CD146 FITC conjugates and CD105, HLA-DR, CD29, CD44, CD49e - APC conjugated (Affimetrix
eBiosceince, ThermoFisher Scientific). Control samples were labelled with isotype-matched
control antibodies IgG1K-FITC and IgG1K-APC (Affimetrix eBiosceince). In brief, cells were
trypsinized and aliquoted at a concentration of 2.5 × 105 cells ml-1, fixed in 0.5%
paraformaldehyde for 30 min at 4 °C, and washed once in PBS 1X. Next, samples were
incubated with either conjugated specific antibodies or isotype-matched control at the
manufacturer’s recommended concentrations, diluted in PBS 1X supplemented with 5 % FBS
(FACS buffer). Labelled cells were washed twice, suspended in FACS buffer, and analysed
using a FC500 flow cytometer (Beckman Coulter).
Chondrogenic differentiation was induced using the micromass pellet culture technique as
described previously [34], [35]. Briefly, 2.5 × 105 confluent P03 cells ml-1 were placed in 1.5
mL screw cap tubes (Sarstedt), centrifuged at 400g for 5 min to form the pellets and cultivated
with either non chondrogenic control medium consisting of DMEM high-glucose (Lonza), 100
U ml−1 penicillin and 100 μg ml−1 of streptomycin (Gibco), 1X Glutamax (Gibco), and 15 mM
HEPES (Gibco), or chondrogenic medium consisting of DMEM high-glucose (Lonza), 100 U
ml−1 penicillin and 100 μg ml−1 of streptomycin (Gibco), 1X Glutamax (Gibco), and 15 mM
HEPES (Gibco), 1% insulin–transferring–selenium (Sigma-Aldrich), 100 nM dexamethasone
(Sigma-Aldrich), 50 mg/mL ascorbate-2-phosphate (Sigma-Aldrich), 10 ng/mL TGFb3
(Prepotech), and 10 ng/mL BMP6 (R&D Systems).
Osteogenic differentiation was induced at P03 by seeding hADSCs in α-MEM supplemented
with 2% FBS in six-well plates at 5 × 105 cells per well. The next day, an osteogenic
inducing cocktail composed of 10 mM β-glycerophosphate (Sigma, St. Louis, MO, USA), 50
μg/mL ascorbic acid (Sigma) and 100 nM dexamethasone (Sigma) was added.
As a negative control, cells seeded under the same conditions were maintained in a noninducing medium.
The medium was changed every 2 days and three biological replicates [n = 3] per time point
and type of analysis at 0 and 4 weeks of culture/group were processed. Immuno/histochemistry
and Reverse transcription-Quantitative Polymerase Chain Reaction (RT-qPCR) were
performed as described below.
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2.4. Generation of Bioscaffolds with the Biopen
Co-axial extrusion was performed using the handheld extrusion system (Biopen) using the
same parameters previously described [31]. Briefly, both Biopen chambers were loaded with
10% GelMa-2% HAMa. hADSCs were mixed to a final concentration of 10 × 106 cells ml-1
and carefully loaded in the core chamber, while for the shell chamber 0.1% w/v Lithiumacylphosphinate (LAP) (Tokyo Chemical Industry Co., Tokyo, Japan) was mixed through the
GelMa/HAMa. The temperature of the solutions was stabilized at 37 °C prior to preparation.
Samples were Biopen extruded into PDMS moulds to produce disc-like shaped bioscaffolds
(height = 1 mm, diameter = 10 mm). Immediately after extrusion the samples were then UV
irradiated at room temperature for 10 seconds, using a 365 nm UV source (Omnicure LX400+,
Lumen DynamixLDGI) fitted with a 12 mm lens (25 mm focal distance) with a light intensity
of 700 mW/cm2.

2.5. In vitro culture of bioscaffolds
The generated bioscaffolds were then transferred to a 24 well plastic plate, washed three times
in PBS 1X and 1mL of chondrogenic or control medium was added to each well. Pictures of
the entire samples were taken with a 7 megapixel camera.
Chondrogenic differentiation was induced as previously described for the pelleted culture cells
(paragraph 2.3.2.) and three biological replicates [n = 3] per time point and type of analysis at
0, 4 and 8 weeks of culture/group (differentiated vs undifferentiated) were processed.

2.6. Histological analysis
For chondrogenic analysis, pelleted cells and Biopen manufactured samples were fixed in 1%
paraformaldehyde (Santa Cruz Biotechnology, Dallas, TX, USA) for 4 h at room temperature,
embedded in O.C.T. TM Compound (Tissue-Tek, Sakura, Leiden, Netherlands) and flash
frozen in liquid nitrogen. Cryosections of 10 m thickness were mounted onto glass slides and
stained with Safranin O (Sigma-Aldrich) for 10 min, dipped in 95% and 100% EtOH, cleared
three times for 1 min each in Xylene (Chem-Supply, GILLMAN, SA, Australia) and then
mounted in Pertex medium (Grale HDS, Ringwood, VIC, Australia).
For osteogenic differentiation analysis, cultured cells were stained with Alizarin Red-S (ARS) (Sigma) to reveal the deposition of a calcium-rich mineralized matrix [36]. Quantification
of Alizarin was performed by Cetylpyridinium chloride extraction and spectrophotometric
measurement at 562nm.
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Samples were imaged using an epifluorescent inverted NikonTiE microscope equipped with a
DS-Ri2 and NIS-Elements software using a PlanFluor ELWD 20X DIC L NA 0.45 objective.
Figure panels were assembled using Photoshop software (Adobe).

2.7. RNA extraction and RT-qPCR
Total RNA from hADSCs, cultured, pelleted or bioprinted, were harvested at indicated time
points using Tri Reagent (Ambion, Austin, TX, USA) according to the manufacturer’s
protocol. DNA contamination were digested by DNAse I (Sigma). Reverse transcription (RT)
was performed using Omniscript reverse transcription kit (Quiagen) following the
manufacturer’s protocol. The relative amounts of COl2A1, COL1A2, ACAN, SOX9, RUNX2,
COL10A1, RPL13 and GAPDH RNAs were evaluated with TaqMan Gene expression assay
(Applied Biosystems, Foster City, CA, USA) using the following probes:
SOX9 (Hs00165814_m1), ACAN (Hs00153936_m1), COL2A1 (Hs00264051_m1) and
COL1A2 (Hs00164004_m1) RUNX2 (Hs01047973_m1), COL10A1 (Hs00166657_m1) as
target genes; GAPDH (Hs02786624_g1) and RPL13a (Hs04194366_g1) as housekeeping
genes. qPCR was performed on a QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher
Scientific) and relative quantification was calculated with the 2E−ΔΔCT method. The mean
ΔCT value of the control sample was used in each experiment to calculate the ΔΔCT value of
sample replicates by using an average of two different housekeeping genes (RPL13 and
GAPDH). Statistical analysis on the data obtained was performed by using unpaired T-Test on
three experimental replicates by considering significative data with a P value < 0.05. Graphs
were designed using Prism 5 software (GraphPad) and figure panels were assembled using
Photoshop software (Adobe).

2.8. Protein extraction and Western blot analysis
Biopen printed samples were collected at the indicated time points, washed three times for 5
min each with PBS 1X on a rotating platform at room temperature, transferred in a 1.5mL
Eppendorf tube, then flash frozen in liquid Nitrogen and stored at -80°C. Whole protein content
was extracted on ice by manually break with a pestle in 30 l/samples of 2X RIPA buffer (750
mM NaCl, 5% Triton X100; 2.5% Sodium Deoxycolate; 10% SDS; 1M Tris, pH 8) with the
addition of protease inhibitor cocktail (Roche). Samples were incubated on ice for 20 min and
cleared by centrifugation at 14000 rcf for 20 min at 4 °C. The supernatant was recovered and
carefully

transferred

in

a

new

labelled

tubes.

Protein

extract

was

quantified

12

spectrophotometrically with the BCA Protein Assay (Thermo scientific). The same amount of
proteins was separated in loading buffer (Thermo scientific) in 4%-12% Bolt Bis-Tris precast
Gel (Thermo scientific) in MES buffer (Life technologies) for 30 min at constant voltage (180
V). Spectra Multicolor Broad range protein ladder (Thermo scientific) was used as a protein
standard. After the electrophoretic separation, proteins were blotted to PVDF membrane with
iBlot 2 system (Life Technologies), following manufacturer’s instructions. Protein transfer was
assessed by Ponceau (sigma) staining. The membrane was blocked against non specific
bindings with 5% non-fat dry milk (Coles) in TBS-T (50 mM Tris-Cl, pH 7.6; 150 mM NaCl;
0.1% Tween 20) for 1 h at room temperature. After three washes in TBS-T for 10 min, the
membrane was incubated overnight at 4 °C with rabbit monoclonal anti human SOX 9 antibody
(#EPR14335, Abcam) or mouse monoclonal anti human β-Actin (#A5316, Sigma Aldrich) in
3.5% Bovine Serum Albumin in TBS-T. After three washes in TBS-T for 10 min, the
membrane was incubated for 1 h at room temperature with anti-rabbit secondary antibody HRP
conjugated (Dako). Finally, after three washes in TBS-T for 10 min, the signal was revealed
with Western Blot Lightning ECL pro kit (PerkinElmer) and imaged with Chemidoc MP
imaging system (Biorad). Figure panels were assembled using Photoshop software (Adobe).

2.9. Immunostaining analyses and fluorescent imaging
For fluorescence analysis, 10 m thickness slices from both pelleted cell culture and Biopen
printed, were washed three times in PBS1X and permeabilized for 15 min in PBS 1X-0.1%
TritonX-100 (PBT). Antigen retrieval was performed only for hydrogel printed samples by
adding 1mg/mL Hyaluronidase (SIGMA, #H6254) diluted in PBS 1X and incubating 30 min
at room temperature. After three washes 5 min each in PBS 1X, samples were dropped in
Blocking solution (10% goat serum diluted in PBT) for 60 min at room temperature and then
incubated overnight at 4 °C with mouse anti-human Collagen II (#II6B3, DSHB), goat antihuman Collagen I (#sc8784, Santa Cruz), mouse anti-human Proteoglycan (#MAB2015,
MerckMillipore) and mouse anti-human Collagen X (#ab49945, Abcam), diluted 1:250 in
blocking solution. The day after, samples were washed three times for 10 min each and
secondary antibodies both diluted 1:100 in blocking solution were added, respectively antimouse IgG Alexa Fluor-647 (#715-605-151, Jackson Immuno Research) and anti-goat IgG
Alexa Fluor-546 (#A11056, Thermo Fisher Scientific Inc.), and incubated for 2 h at room
temperature. After three washes 5 min each in PBS 1X, actin was labelled with Texas Red-X
Phalloidin (#T7471, Thermo Fisher Scientific Inc.) 1:100 diluted in PBS 1X for 60 min at room
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temperature and nuclei were stained by incubation with 5 µg/mL DAPI (Thermo Fisher
Scientific Inc.) diluted in PBS 1X for extra 60 min at room temperature.
The sections were washed three times 5 min each in PBS 1X, mounted with Fluoromount-G
(Southern Biotech, Birmingham, AL, USA) onto glass slides. Pellet sections were imaged
using an epifluorescent inverted NikonTiE microscope equipped with a DS-Ri2 and NISElements software using a Plan Fluor ELWD 20X DIC L NA 0.45 objective. Biopen printed
samples were imaged with NikonA1R confocal microscope using a Nikon Plan
VC 20x DIC N2 N.A. 0.75 objective lens and “Scan large image” from NIS-Elements software
tool was used to image a larger field of view.
Digital images were processed using NIS-Elements software (Nikon, Amsterdam, Netherlands)
and Photoshop software (Adobe) was used to assemble the figure panels. All the images shown
in this study are representative of at least three independent experiments.
The fluorescence measurement analysis of Figure 6C was performed with the “Annotations and
Measurements” feature of NIS-Element software.
The intensity of the Collagen type II corresponding channel was calculated by normalizing the signal
for the identified positive area. The percentage of the positive area was calculated in relation to the total
area of the field of view, which was the same for all the images acquired and that corresponded to 3mm2.
Those analyses were performed on three different fields of view for each sample.

2.10. Second Harmonic generation Microscopy
Regions of interest images (5 mm x 5 mm) were acquired on a fully automated, programmable,
multiphoton imaging platform (Genesis® 200, HistoIndex Pte Ltd, Singapore) following
sectioning and mounting of 10 μm-thick cryosections washed out from OCT. Laser excitation
occurred at 780 nm. Forward-scatter two-photon excitation (TPE) and second harmonic
generation (SHG) signals were detected using dedicated photomultiplier tubes for each
channel. Magnification was set to 20x. TPE sensitivity was set to 0.7, and SHG sensitivity to
0.6. A bandpass filter with center wavelength at 550 nm and bandwidth of 88 nm was set in
front of the TPE photodetector. Laser baseline power was set at 0.5, and then stepped down by
60% using a set of 2 optical attenuators (0.1OD, 0.3OD - “Low” laser power configuration).
No change was made to the polarization of the laser source, and no polarization was used on
the SHG detection channel. Tissue areas were scanned once with no frame averaging feature.
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2.11. Whole sample staining and light sheet imaging
Entire bioscaffolds were transferred to clean 12 well plates, washed 3 times 10 min each in
PBS 1X and fixed in Paraformaldehyde 4% for 30 min. After washing three times for 10 min
each in PBS 1X, samples were permeabilized in PBT (0.1% Triton in PBS 1X) for 60 min.
Actin was labeled with Texas Red-X phalloidin (#T7471, Thermo Fisher Scientific Inc.) 1:100
diluted in PBS for 2 h. The excess of phalloidin was removed by washing 3 times 10 min each
in PBS 1X. Nuclei were stained by incubation with 5 µg/mL DAPI (Thermo Fisher Scientific
Inc.) diluted in PBS 1X for extra 60 min. Samples were finally washed 3 times 10 min each in
PBS1X and left at 4 ºC until imaging.
For light sheet imaging, samples were hooked and loaded in a glass capillary (size 2 black,
inner diameter of capillary ~1mm, #701932, BRAND GmbH). The glass capillary was
mounted in the chamber, which was filled PBS 1X. A Lightsheet Z.1 microscope (Carl Zeiss
Microscopy GmbH, Jena, Germany), with 20×/1.0 NA water dipping detection objective and
two-sided 10×/0.2 illumination optics, equipped with two PCO EDGE 4.2 cameras (sCMOS
sensor, square pixels of 6.5×6.5 μm side length, 2048×2048 pixel resolution, 3-channel images,
16 bit dynamic range) (PCO AG, Kelheim, Germany) were used for light sheet imaging. For
DAPI and Phalloidin-actin 1.5%-405 nm and 8.6%-561 nm laser powers respectively and 50
ms exposure time were used. Pivot scanning mode (Carl Zeiss) was used to deliver
homogeneous illumination and prevent shadows along the illumination axis. For all 3D
datasets, a z-interval of 2 μm with a zoom of 0.50 was used. The volumetric images were
1131×1131×1000 μm (1920×1920×500 pixels) in size, with 0.589×0.589×2.000 μm3
resolution. To counteract the degradation of the light sheet by the high amount of scattering,
the specimen was sequentially illuminated through each of the two opposing illumination
objectives, generating pairs of illuminated single-side images, and then combined into fused
single illumination optical sections with a considerably improved penetration depth. All
acquired LSFM raw data were processed using ZEN 2011 imaging software (Carl Zeiss,
Germany). Optical sections were merged and combined into a single three-dimensional data
set and reconstructed using IMARIS 9.0 software.
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2.12. Compression testing
The tests were performed at room temperature using a TA Electroforce 5500 mechanical
loading device (TA Instruments, New Castle, USA) fitted with a calibrated 22 N load cell. The
contact point between the two plates was recorded. Then, the sample was placed between two
4.2 cm diameter compression plates, in an unconfined setting as previously described [37]. The
displacement of the upper plate was controlled by a ramp function, at a rate of 0.01 mm/s, until
a total displacement of 25% of the sample height. The contact area of the sample with the plate
was measured by microscopy imaging before the test. Additionally, the point of inflexion of
the load versus time curve showed the contact point between the sample surface and the
compression plate to give the sample height. Load and displacement measurements were
converted into stress (σ) and strain (ε) data using the sample surface area and height. The
compressive modulus was then computed using stress data between 10 and 15% strain as
follows: Ec = (σ15 −σ10 )⁄(ε15 − ε10 ).
Three biological replicates [n = 3] for each of the three patients per time point and type of
analysis at 0, 4 and 8 weeks of culture/group (differentiated vs undifferentiated) were
processed. Data Graphs were designed using Prism 5 software (GraphPad).

2.13. Atomic Force Microscopy
AFM nanoindentation was performed on an MFP-3D (Asylum Research) using a contact
mode MLCT probe (Bruker Nano Inc.) with a stiffness calibrated as 0.135 N/m. Force curves
were performed to an indentation force of 5 nN at an approach rate of 2 m/s. The Young’s
Modulus was obtained using the Hertz indentation model approximating the tip-shape as a
19.2 cone. Bioprinted hydrogel samples were submerged in PBS 1X during measurement.
For each bioprinted sample, 16 indentations across 5 regions were performed in a
standardized fashion, making 80 force curves per sample. Three samples for each of the
control week 8 and chondrogenic week 8 groups were measured. The same AFM probe was
used for all measurements.

2.14. Statistical Analysis
All statistical analyses were performed using Prism 5 (GraphPad) software with a statistical
significance level of 0.05. Differences between the experimental groups were determined using
unpaired t test or one-way Anova tests with Dunnett’s corrections as indicated. In all graphs
stars represents * is p ≤ 0.05; ** is p ≤ 0.01; *** is p ≤ 0.001; not significant (n.s.) is p>0.05.
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3. Results
3.1. Comprehensive profile analysis of hADSCs identifies the infrapatellar fat pad as a
source of stem cells for in situ biofabrication
We isolated infra-patellar adipose derived stem cells (hADSCs) from three patients undergoing
total joint knee replacement and characterized their stemness and differentiation potential. To
account for any possible inter-patients variability, we decided to test our biofabrication strategy
on different stem cells derived lines from patients’ donors.
We first evaluated the cell morphology, plastic adherence after isolation, and the expression of
typical stemness surface markers. The three lines displayed the typical spindle-shaped
appearance at early passages and exhibited a smoothened morphology after long-term
expansion, developing a larger and more granular cytoplasm (data not shown). Flow cytometry
analysis documented that >90% of hADSCs expressed CD90, CD73, CD105 CD29, CD49.
More than 90% of cells were also positive to the hyaluronan receptor CD44, which role is
important in the early stages of cartilage development [38]. More than 60% of hADSCs were
positive for HLA-DR, whereas the expression of the hematopoietic markers CD14, CD31,
CD34, CD45 was <3%. The markers CD106 and CD146 were expressed in less than 10% of
hADSCs as previously shown [39]. No significant difference among the three patients was
scored, confirming that with our established laboratory procedures we are able to isolate and
expand a homogenous stem cell population despite the donor tissue variability (Supp. figure
1). The chondrogenic potential was then tested by pellet culture in vitro during a period of 4
weeks, and production of chondral extracellular matrix (ECM) was confirmed (Figure 3).
The initial assessment of chondrogenesis was based on the size and appearance of the pellets.
After their generation, pellets grew in size and displayed a consistent white opaque
macroscopic appearance (Figure 3(A)). Safranin O staining showed accumulation of
Glycosaminoglycans (GAGs) deposition (Figure 3(A)) and changes in cell morphology from
round shapes at week 0 to elongated cells encapsulated by an abundant ECM in the entire pellet
structure (Figure 3(A)). Gene expression data confirm the increase expression of Collagen type
II (COL2A1) and type I (COL1A2), Aggrecan (ACAN) and Sox-9 (SOX9) markers during the
differentiation process (Figure 3(B)). COL2A1 and ACAN were not detectable in both 2D and
pellet cultured hADSCs at steady state, but were activated only during the chondrogenesis
process as a consequence of SOX9 increased expression. Finally, the immunostaining analyses
revealed an increased expression of both Collagen type II and I during time, with a much
stronger intercellular accumulation of Col II (Figure 3(C)). As previously shown [34, 35], hADSCs
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from fat pad display the tendency to express higher level of collagen type II RNA and protein respect
to Collagen type I during in vitro chondrogenesis under stimulation of TGFBeta3 and BMP6.

To confirm further the differentiation potential of the isolated populations, we also tested the
osteogenic potential through Alizarin red staining and gene expression (Supp. figure 2).

Figure 3. Comprehensive profile analysis of Infrapatellar Fat Pad derived hADSCs. (A) Histological analysis
on 10 m cryosections stained with Safranin O to detect accumulation of GAG in the ECM. In the bottom left,
the insets show the brightfield images of the whole pellets. The small panel on the right upper corner at Week 4
shows a higher magnification image of cells encapsulated and surrounded by the ECM. (B) The graphs represent
the fold changes calculated with 2^C method of Collagen type II (COL2A1) and type I (COL1A2), Aggrecan
(ACAN) and Sox-9 (SOX9) markers. Fold Changes were normalized for RPL13a and GAPDH. Error bars
represents standard deviation between three biological replicates and significant activity was calculated with
unpaired t-test. These analyses have been performed on the hADSCs lines derived from three different patients
and statistical analyses were performed as described in Materials and Methods section. (C) Immunostaining
analysis on 10µm cryosections from pellet at Week 0 and Week 4 of chondrogenesis, performed using antibodies
against Collagen type II (Col II) and I (Col I) shown in green, and DAPI shown in violet to detect cells nuclei.
Note: the images in A and C are the most representative selected from the immunohistology performed on the
three hADSCs patient derived cell lines.
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3.2. Neocartilage generation in vitro
3.2.1. GAG accumulation during chondrogenic differentiation of hADASCs in
GelMa/HAMa bioscaffolds
We used the Biopen to generate bioscaffolds in which hADSCs were laden in Gelatin
Methacrylate (GelMa) and hyaluronic acid methacrylate (HAMa). Both Gelatin (denatured
collagen) and hyaluronic acid retain relevant cell-binding sites, while the addition of
methacrylate groups renders the material amenable to rapid crosslinking using light, creating
a hydrogel structure which is stable at physiological temperatures and achieves mechanical
properties approaching that of native hyaline cartilage. As described in our previous paper
[31] the 10s crosslinking time at 700 mW/cm2 with a 365 nm UV light source do not cause
proliferation inhibition to hADSCs in the same core/shell bioprinting conditions.
We produced tridimensional structures of the size of a critical cartilage injury, where a critical
size implies a defect which will not heal spontaneously without any intervention [40][41].
The neocartilage development was first qualitatively evaluated via the appearance of the
bioscaffolds. The macroscopic brightfield images showed a marked difference in the opacity
of the printed samples (Figure 4(A)) with a consistent white opaque macroscopic appearance
developing over time only in the chondrogenic stimulated samples and not in the control group
(Figure 4(A)).
The deposition of the ECM in the hydrogel matrix was then verified histologically, by staining
the sections derived from the same samples with Safranin O, as a reporter of GAG content [42]
(Figure 4(B)). In the acellular scaffold, Safranin O stains a non-homogenous material. On the
other hand, in the cell-laden bioscaffolds, the stem cells occupied defined lacunae in the
surrounding hydrogel and exhibited a round shaped morphology when maintained in a control
non-chondrogenic media.
Upon chondrogenesis, the bioscaffolds showed a progressive formation of a compact and
homogeneous matrix at Week 4 and Week 8 that is positive to Safranin O, demonstrating the
accumulation of GAG (Figure 4(B)). The cells appeared elongated throughout the GAG
forming a continuous structure. This analysis indicated a cell response to chondrogenic stimuli
in GelMa/HAMa bioscaffolds and the consequent accumulation of GAG over time.
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Figure 4. Neocartilage building and evaluation of GAG accumulation in Biopen extruded bioscaffolds.
(A) Photographs show bioscaffolds from the control and the chondrogenic groups at the indicated time points.
The white boxes outline the areas imaged in the histological analysis shown in the corresponding panels below.
(B) Histological analysis from the corresponding samples of 10 µm cryosections, stained with Safranin O dye.
Images were acquired with a 20X objective lens. Note: the images in A and B are the most representative selected
from the analyses performed on bioscaffold constituted by three hADSCs lines derived from three different
patients.

3.2.2. Gene expression analysis evidences chondrogenic differentiation of hADSCs in
GelMa/HAMa bioscaffolds
To elucidate the capability of hADSCs to undergo chondrogenesis in the bioscaffolds, we
analysed the gene expression of chondrogenic markers over a period of 8 weeks by RT-qPCR
and Western blot analyses.
The three hADSCs lines showed a progressive increase of the master transcriptional regulator
of the chondrogenic program SOX9 both at transcriptional and translational level [43] [44]
(Figure 5(A, B)).
The intracellular accumulation of SOX9 led in turn to a progressive activation of its target
genes COL2A1 and ACAN (Figure 5(A)). The three hADSCs lines did not exert any basal
expression of the ECM components before the induction of chondrogenesis, as also
confirmed by electrophoretic analysis of PCR amplified cDNA (Figure 5(A), lower panels).
ACAN and COL2A1 expression was detectable 4 weeks after the start of the chondrogenesis
differentiation, exerting an average fold change of 20 and of 140 respectively during the
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following 4 weeks. hADSCs already expressed COL1A2 before the chondrogenesis
differentiation and its level increase during time. Nevertheless, COL1A2 showed only a 10
fold increase from week 0, while Collagen type II, which was not detectable at week 0, increases
up to 200 folds at week 8 compared to week 4. Thus, the ratio between COL2A1 and COL1A2

indicated the generation of hyaline-like cartilage rather than fibrocartilage, as described in
previous works [45] [46] and in agreement with pellet culture data (Figure 3).

Figure 5. Cellular response to chondrogenic stimuli. (A) The graphs represent the fold changes calculated with
the ^C method of Collagen type II (COL2A1) and type I (COL1A2), Aggrecan (ACAN) and Sox-9 (SOX9)
markers. Fold Changes were normalized for RPL13a and GAPDH. Error bars represents standard deviation
between three biological replicates and significativity was calculated with unpaired t-test. These analyses have
been performed on lines derived from three different patients. The lower panels show the electrophoretic analysis
of the amplified cDNA to underline the switch in COL2A1 and ACAN expression during chondrogenesis.
(B) Western Blot analysis of SOX9 protein expression in hADASCs undergoing chondrogenesis in GelMa/HAMa
bioscaffolds.
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3.2.3. Generation of hyaline-like cartilage
To analyse the process of biofabrication of chondral tissue in our Biopen extruded samples, we
cryosectioned the bioscaffolds at the indicated time points and performed histological analysis
by immunostaining with antibodies against Collagen type II (Col II), Collagen type I (Col I)
(Figure 6) and Proteoglycan (Supp. figure 3) . The data obtained matched the gene expression
analysis: Col I was already expressed at the start of the chondrogenic differentiation, while Col
II was detected after 4 weeks (Figure 6(A)).
Despite the fact that the intensity of the Col I signal increased during chondrogenesis, the
intercellular Col II deposition and accumulation in the hydrogel matrix dramatically differed
from Col I, reaching a strong and uniform pattern at week 8 of chondrogenesis. The thickness
of the Col II-rich stripe increased from an average length of 400 m at week 4 up to 800 m
at week 8 (Figure 6(A)). Those data are consistent with RT-PCR expression analyses where
we demonstrated that the ratio between Collagen II and I is in favor of Collagen type II higher
expression. Those results correlates with the generation of hyaline-like neocartilage.

To confirm these data we analysed the fluorescence intensity profile and the relative percentage
of the area that was positive for Col II on three fields of view for each of the three patient
derived cell lines (Figure 6(B)). The results showed a significant difference in the fluorescence
intensity between the samples collected at the start of the chondrogenesis and the differentiated
samples at week 4 and week 8 on an area of 3 mm2 for each field analysed. Moreover, the
fluorescent area was 26% of the 3 mm2 area at week 4 with a significant increase up to 40% at
week 8 (Figure 6(C)). The changes in cell morphology during differentiation represents an
important feature to estimate the degree of chondrogenesis [47]. As detected by actin staining
of cytoskeleton, hADSCs modified their morphology over time from round shape to a more
elongated appearance (Figure 6(B)). Collagen type II was strongly concentrated along the cell’s
membranes and in the extracellular matrix, while collagen type I remained confined in the
intracellular area (Figure 6(B)). Moreover, Collagen type X, a marker of hypertrophic
differentiation, resulted to be expressed after 4 weeks of chondrogenesis, also with an
intracellular accumulation (Supp. figure 4).
Conversely, in the control bioscaffolds, in absence of chondrogenic stimuli, the expression of
Collagen type I and II was not detectable (Supp. figure 5).
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Figure 6. Neocartilage building and accumulation of Collagen type II. (A) Immunostaining analysis on 10
µm cryosections from Biopen biofabricated samples at Week 0, Week 4 and Week8 of chondrogenesis, performed
using antibodies against Collagen type II (Col II, in green), Collagen Type I (Col I, in cyan) and counterstained
with cell marker nuclei DAPI (in grey) and Texas Red-X phalloidin Actin (in red) to detect cell morphology. The
superimposed signals are shown in the last columns (merge + Nuclei Actin). The images are orientated with the
surface of the samples toward the top. (B) The panels show higher magnification of sections shown in A. Note:
the images are the most representative selected from the immunohistology performed on the three hADSCs patient
derived cell lines. (C) The graph shows the quantification analysis of Col II fluorescence intensity normalized for
the positive area (bars) and the percentage of the positive area for Col II (area fill). The calculations were
performed on three different fields of view. One way Anova with Dunnett’s correction was applied to statistically
analyse the differences in the fluorescence intensity, while unpaired t test was used for the fluorescence area.

In order to visualize the spatial distribution of cells and ECM deposition along the
differentiation, we used Light Sheet microscopy, which allows, the reconstruction of a 3D
image, while maintaining the physiological integrity of the bioscaffold, through optical sectioning
of the sample. We labelled the bioscaffolds with Actin to detect cells and with Collagen type
II to detect ECM generation. From our imaging analysis, we observed how hADSCs exerted
the ability to condense in the GelMa/HAMa hydrogel scaffold during the chondrogenesis
(Figure 7). Cells are evenly distributed along the entire depth of the printed scaffold right after
the printing (Figure 7(A, C)), but condensed toward the superficial areas of the bioscaffolds
during the chondrogenic differentiation (Figure 7(B, D)). In contrast, the condensation
phenomenon was not visible without chondrogenic stimuli (Supp. figure 4). Collagen type II
deposition is clearly visible at week 4 in the area where cells are condensed. The stem cell
condensation is in fact required for the inception of the chondrogenic program during limb
development [48] [49].
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Figure 7. Neocartilage building and cells condensation during chondrogenesis. (A,B) Immunostaining
analysis on 10 µm cryosections from Biopen biofabricated samples at Week 0 and Week 4 of chondrogenesis,
performed using Texas Red-X Phalloidin (in red) to detect cell condensation. (C,D) Light sheet microscopy
performed on the entire bioscaffolds (shown in grey, 1 mm height) at Week 0 and 4, after labelling with Texas
Red-X Phalloidin and Collagen type II antibody. The stained Actin is shown in red in the superimposed panel
with the bioscaffold (left column), and in rainbow colour code to show the depth and the localization of cells
throughout the entire depth of the bioscaffold (middle column). The raibow color code represents a range of depth
that goes from 0 mm (violet colour) to 1 mm (red colour). Collagen type II is shown in green (right column) to
detect neocartilage formation. The images are orientated with the surface of the samples toward the top.
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3.2.4. Collagen II fibrillary organization in GelMa/HAMa bioscaffolds
Visualization of the 3D arrangement of the extracellular matrix (ECM) and living cells in native
hydrated conditions is crucial to ensure the formation of a hyaline-like tissue [49]. In addition,
it is important to understand if the accumulation of Collagen type II is combined with the
organization of mature collagen fibrils that provides the strength and the function to the
neotissue.
Hence, the immunohistochemistry analysis was complemented with nonlinear microscopy, a
non-invasive methodology that allows to simultaneously acquire second-harmonic generation
(SHG) images of collagen and two-photon excited autofluorescence (TPE) images of living
cells in label-free biofabricated scaffolds (Figure 8(A)).
In the acellular scaffolds that were maintained in chondrogenic media for 8 weeks, TPE and
SHG were not detectable, indicating that the composition of GelMa/HAMa did not interfere
with the two signals’ generation (Figure 8(B)). In the chondrogenic induced bioscaffolds, we
were able to detect TPE signals from cells embedded in the GelMa/HAMa and SHG derived
image of collagen fibrils surrounding the cells (Figure 8(D)). In contrast, in absence of
chondrogenic stimuli, only TPE signal was detectable (Figure 8 (C). The collagen-like fibrils
detected by SHG are only attributable to the building of neocartilage from stem cells
undergoing chondrogenesis. Importantly, given that the corresponding immunostaining
performed on the same sections was able to detect only Collagen type II protein accumulation
in the ECM, rather than Collagen type I or Collagen type X (Figure 6 and Supp. Figure 3),
mature Collagen type II can be considered as a major contributor of the SHG signal.

26

Figure 8. Neocartilage building and organization of collagen type II fibrils. (A) Schematic cartoon showing
the non-linear microscopy whereby dual-photon excitation gives rise to two-photon excitation (TPE) and second
harmonic generation (SHG). Under dual-photon excitation conditions, non-centrosymmetric structures (such as
collagen molecules) absorb and release energy in a different way to subcellular proteins. The light emitted from
the excited non-centrosymmetric structures return at double energy, but half the wavelength of the original
excitation photons generating images of the fibrillary structures of collagen proteins. (B) Representative image of
the acellular control scaffold. (C) Representative images of hADCSs laden in GelMa/HAMa after 8 weeks in
control media. (D) Representative images of hADCSs laden in GelMa/HAMa after 8 weeks of chondrogenic
differentiation. Note: Samples have been fixed and cryosectioned and directly imaged for non-linear microscopy
(see Material and Methods section for more detailed information).
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3.2.6. Mechanical evaluation of GelMa/HAMa bioscaffolds during chondrogenesis
In order to characterize the functional development of the in vitro generated tissue, we used
unconfined compression testing (Figure 9) on the three hADSCs cell lines in triplicate for each
indicated time point. The unconfined compressive modulus measured in non chondrogenic
bioscaffolds was 57.28 kPa (+/-26.8) and 29.9 kPa (+/- 23.4) after 8 weeks of chondrogenesis
without any significative difference between the groups (Figure 9(A)).
Moreover, the bioscaffolds exerted a compressive modulus of 61.2 (+/- 36.5) at week 0 (data
not shown). Overall, we measured that the bioscaffolds maintain consistent mechanical
properties along the chondrogenic differentiation. However, by analysing the surface of our
bioscaffolds at a microscale level by Atomic Force Microscopy indentation, we found that the
Young’s modulus of five different localized area of three different samples was 660 kPa (+/1119) after 8 weeks of chondrogenesis and only 191.7 kPa (+/- 140.7) in their relative non
chondrogenic controls. The high variability of the chondrogenic samples reflects the
accumulation of biological derived ECM, for which organization is based on collagen fibrils
and cannot result in a flat homogeneous surface. The stiffness is on average 3.45 times higher
than their control counterparts, which in contrast showed a much lower standard deviation
(Figure 9(B)).
Thus, the secreted matrix causes a gain in mechanical strength that cannot be detected by
unconfined mechanical tests due to the non-homogeneous organization of the neocartilage
through the entire thickness of the sample.
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Figure 9. Mechanical properties evaluation. (A) The graph shows the unconfined compressive modulus of
control and chondrogenic samples after 8 weeks. Error bars represents standard deviation between three biological
replicates and significativity was calculated with unpaired t-test. (B) The graph indicates Young’s modulus values
obtained from analysing force curves using the Hertz indentation model of control and chondrogenic samples after
8 weeks. .Error bars represents standard deviation between three biological replicates and significativity was
calculated with unpaired t-test. These analyses have been performed on three hADSCs, undergoing chondrogenic
differentiation, derived from three different patients.

4. Discussion
The results of this study demonstrate that the Biopen can be used to produce human hyalinelike cartilage in vitro by co-axial extrusion of adipose-derived stem cells (hADSCs) laden in
GelMa/HAMa hydrogel.
The necessity for the development of a handheld device is dictated by surgical needs: cartilage
injuries have to be cleaned and debrided before any regenerative solution can be attempted
surgically, therefore impeding the perfect matching of laboratory-produced bioscaffolds.
In this study, we have used the handheld extrusion device (Biopen) in the same fashion as it
would be used surgically, to simulate its clinical applicability.
The ideal cell type to be used for cartilage regeneration is still a matter of debate. A number of
cell sources have been investigated, the most common being mature articular chondrocytes,
chondrocyte progenitors, and stem cells [50]. It is accepted that overall mesenchymal stem
cells must possess a proven chondrogenic capacity, must not cause donor-site morbidity, and
must be readily expandable in culture without losing their phenotype [51]. The number of stem
cells-based clinical trials currently running worldwide and focused on cartilage repair is in fact
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increasing [52]. Recently, a group of stem cells isolated from joint tissue, such as chondrogenic
stem/progenitors from cartilage itself, synovial fluid, synovial membrane, and infrapatellar fat
pad (IPFP) have gained great attention due to their increased chondrogenic capacity over the
bone marrow and subcutaneous adipose-derived stem cells [53]. Indeed, the infrapatellar fat
pad, has gained much attention as a source of hADSCs with high chondrogenic capacity both
in vitro and in tissue regenerative medicine approaches [53]. Human ADSCs also express
CD44, which is the Hyaluronic Acid receptor involved in cell-cell and cell-matrix interactions,
therefore playing an important role in the early stages of cartilage regeneration [54]. By
expressing CD44, these cells are more prone to bind the hyaluronic acid residues present in the
GelMa/HAMa bioink favouring the chondrogenic process. Therefore, for our study we have
selected hADSCs harvested from the infrapatellar fat pad, as the source for human cartilage
regeneration. Furthermore, we have shown that stem cells isolated from the IPFP of patients
affected by mild/severe OA, retain their chondrogenic potential, thus establishing the milestone
for the treatment of cartilage injuries via using a personalized medicine approach using
autologous stem cells [55]. Despite the heterogeneity of the clinical status of the patients, the
data obtained showed consistent results among the different stem cells lines tested, defining
our stem cells source, the human fat pad, as a good candidate for the clinical application.
In our previous study we have demonstrated that a core/shell distribution of our scaffold
reliably protects the survival and proliferation capacity of hADSCs [31].
The co-axial extrusion approach have been proposed by other groups, they aimed to use a
viscous sacrificial shell to allow the deposition of a liquid cellular compartment that cannot
otherwise hold a predetermined shape, thus performing the hardening procedure before the
removal of the sacrificial compartment [56] [57] [58].
The advantage of our technology relies instead on a different application of core/shell
geometry. The segregation of the photocrosslinkable shell away from the cellular compartment,
which is not photocrosslinked, is designed to protect the cells during the biofabrication process
without compromising structural or cellular integrity. Our co-axial strategy geometrically
compartmentalizes a solid phase that facilitates appropriate stiffness requirements, and a
viscous liquid phase that preserves cell viability by separating cells from PIs and the cytotoxic
chemical by-products coming from the crosslinking reaction going on within the solid phase.
As shown in our previous study [31], the segregation of the core and shell compartments is
well defined right after the biofabrication process.
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Thus, we produced GelMa/HAMa bioscaffolds by means of Biopen mediated co-axial
extrusion to assess whether the fabricated environment is permissive for neocartilage
generation in vitro.
Expression of Hyaline-like cartilage components was assessed first by RT-qPCR. SOX9, the
master regulator of chondrogenesis, is expressed at transcriptional level but not at translational
level before the chondrogenic induction, reflecting the chondrogenic potential of the stem cells
source. However, SOX9 transcript accumulates over time under chondrogenic stimuli,
reaching an expression plateau at week 4, with a consequent accumulation of the translated
protein that continue to accumulate until week 8. This apparent discrepancy can be ascribed to
the several post translational modification that regulates the stability of SOX9 in the cells. In
fact, SOX9 is subjected to ubiquitin mediated proteasomal degradation effected by the E3
ubiquitin ligase FBW7 [59] [60] and by the E6 ubiquitin ligase UBE3A [61]. Moreover, the
activation of TGFb pathway leads to the stabilization of SOX9 by the phosphorylation of Serine
211 [62]. Thus, despite the transcriptional expression of SOX9 reaches a plateau, post
translational modifications, triggered by chondrogenic stimuli, can positively affect the
stability of the protein, leading to the activation of its transcriptional targets. In fact, COL2A1
and ACAN are not expressed at the start of the chondrogenesis, but are detectable at week 4
showing a 300 and 20 fold increase respectively at week 8. COL1A2, an accepted marker of
fibrocartilage formation, is express in hADSCs populations and shows an increase of only 10
times over the entire length of chondrogenic stimulation. This is consistent with other studies
that analyse the chondrogenic potential of 3D bioprinted hADSCs [42]. The production and
accumulation of ECM containing Collagen type II, Proteoglycan and Glycosaminoglycans was
demonstrated in a time-related manner both histologically and immunophenotypically.
hADSCs secreted a significant amount of Collagen type II and Proteoglycan around the cell
bodies and in the scaffold matrix. In contrast, no significant extracellular accumulation of
Collagen type I was observed over time in the analysed bioscaffold. It has been shown that the
ratio between Collagen type II and Collagen type I is the discriminant to define hyaline-like
ECM [63]. After chondrogenic stimulation, the mentioned ratio is considerably higher in the
GelMa/HAMa bioscaffolds both at transcriptional and translational level. Our settings are
consistent with other studies showing Col II accumulation after 28 days of differentiation and
performed using GelMa based bioinks and animal derived stem cells [64]. Moreover, the
production of hyaline-like matrix we observed is highly efficient with respect to that generated
from adult chondrocytes loaded in GelMa ink [65], underlining once again the superiority of
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hADSCs as a source of cells for the production of ECM in scaffold-based cartilage regeneration
applications.
To further characterise our bioscaffolds, we have shown collagen fibrils formation and
distribution using non-linear two photon microscopy and second harmonic generation
(SHG)[66] [67]. This technique can detect only mature fibrillary collagen. Our results
showed that Collagen type I and X are expressed at the intracellular level. In contrast,
Collagen II are secreted and accumulated in an organized extracellular matrix after 8 weeks
of chondrogenesis. Thus, is very likely that mature Collagen II is the major contributor of the
SHG signal.
The pattern of matrix deposition in bioscaffolds resembles the early stages formation of the
growth plate with an accumulation of collagen type II in the surface of the developing tissue.
It is in fact well established that cartilage formation begins with mesenchymal condensation
leading to chondrogenic differentiation of mesenchymal cells. Then, a dense matrix is
produced, serving as the cartilage anlage, a template for the subsequent generation of both the
articular cartilage and the subchondral bone [48][49]. The formation of physiologic tissue by
progenitor cells ultimately required lessons taken from native tissue morphogenesis. Selfassembly has been proposed as an in vitro method for recapitulating mesenchymal
condensation that precedes chondrogenesis [68]. However current tissue-engineered scaffolds
for chondrogenesis pay little attention to this phenomenon or focused more on the modification
of the bioink by adding growth factors or decellularized ECM components to help the cellular
condensation [69], while others use cells pre-clustered into pellets prior to 3D manufacturing
to mimic the mesenchymal condensation [70]. With our setting instead, we demonstrated that
hADSCs are able to condense under in vitro chondrogenic stimulation and successfully
produce hyaline-like bioscaffolds. Moreover, the peripheral distribution of matrix formation is
promising in the view of the entire osteochondral tissue regeneration. In the future, the
possibility to deliver a gradient of osteogenic and chondrogenic growth factors within the
hydrogel could promote the selective tissue differentiation allowing the formation of bone and
cartilage simulating the entire osteochondral unit [71]. Importantly, our culture technique was
performed in a static fashion, therefore not stimulating the orientation of the collagen fibres in
a way to recapitulate hyaline-like cartilage structures. To better simulate the physiological
environment within the joint, the use of a dynamic culture systems will be necessary to improve
the orientation of the collagen fibres, as shown in previous studies [72]. Mechanical resistance
to stress is undoubtedly a key element in cartilage tissue engineering: just like native articular
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cartilage, the regenerated tissue needs to be able to sustain the loads applied on the joint and
distribute them evenly in the underlying subchondral bone. There is currently no consensus on
the expected results from mechanical testing following cartilage regeneration in hydrogels.
While several studies have shown that after 4 or 8 weeks in chondrogenic culture media, 3D
printed samples show increase in the compression modulus [73], other studies show decrease
or stagnation of mechanical properties with time in compression [74], and in tension [75]. In
our study, by unconfined compression tests, we found no statistically significant difference of
the bulk mechanical properties between chondrogenic bioscaffolds and their control
counterparts. Importantly, several studies aiming at cartilage matrix growth in hydrogels
demonstrated a compressive modulus after 8 weeks reaching about 50kPa [73][74] [76], which
is the constant modulus of our hydrogel. While this compressive modulus is achieved during
the chondrogenic process in vitro, with our approach it is possible to obtain a comparable
stiffness right after the biofabrication process. The mechanical behaviour of the bioscaffolds is
determined by the interplay between intrinsic degradation of the biomaterial components, cell
mediated degradation and ECM deposition [77]. However, by performing atomic force
microscopy indentation, we have demonstrated that in correspondence of accumulated ECM
there is a marked increase in Young’s modulus at 8 weeks of chondrogenesis, compared to
undifferentiated samples. This analysis highlights the importance of considering spatial
variations in constructs. These results reflect the fact that ECM accumulation lead to a gain in
mechanical resistance in localized regions that correspond to the area of where cell
condensation happens. In our next studies, the phenotype and migration of the cells, matrix
deposition, proteolytic activity and construct degradation rate will be evaluated and correlated
with de novo cartilage formation to better understand the interaction between hADSCs and
crosslinked GelMa/HAMa hydrogel [78].
5. Conclusion
The clinical application of hydrogel based bioscaffolds has the potential to effect the
regeneration of articular cartilage. In this study, we have demonstrated that human Infrapatellar
Fat Pad Adipose-derived Stem Cells can produce hyaline-like cartilage in GelMa/HAMa
bioscaffolds. The in vitro biofabrication of human neocartilage via a handheld extrusion device
is a key step in the path towards the development of tissue regeneration strategies in the clinical
practice.

33

Acknowledgements
This work was supported by (1) Arthritis Australia – Zimmer Australia Grant, (2) Victorian
Orthopaedic Research Trust, (3) The John Loewenthal Foundation for Surgery (Royal
Australasian College of Surgeons), (4) The Australian Research Council Centre of Excellence
Scheme (Project Number CE 140100012), and (5) St Vincent’s Hospital (Melbourne)
Research Endowment Found.
Equipment Grant form MTPConnect is gratefully acknowledged.
Access to atomic force microscope facilities was provided through the Materials
Characterisation and Fabrication Platform at the University of Melbourne.
The authors would like to thank the Australian National Nanofabrication Facility – Materials
node for equipment use; Dr. Andre Tan for technical assistance in performing SHG
microscopy. Confocal Microscopy and IMARIS software usage were performed at the
Biological Optical Microscopy Platform, The University of Melbourne
(www.microscopy.unimelb.edu.au).

34

References
[1]

Hollander A P, Dickinson S C and Kafienah W 2010 Stem cells and cartilage
development: Complexities of a simple tissue Stem Cells 28 1992–6

[2]

Muiznieks L D and Keeley F W 2013 Molecular assembly and mechanical properties
of the extracellular matrix: A fibrous protein perspective Biochim. Biophys. Acta Mol. Basis Dis. 1832 866–75

[3]

Mansour J M 2009 Biomechanics of Cartilage Kinesiol. Mech. pathomechanics Hum.
Mov. 66–79

[4]

Kon E, Filardo G, Di Martino A and Marcacci M 2012 ACI and MACI J. Knee Surg.
25 017–22

[5]

Makris E A, Gomoll A H, Malizos K N, Hu J C and Athanasiou K A 2016 Repair and
tissue engineering techniques for articular cartilage Nat Rev Rheumatol 11 21–34

[6]

WOOD J J, MALEK M A, FRASSICA F J, POLDER J A, MOHAN A K, BLOOM E
D A T, BRAUN M M and COTÉ T R 2006 AUTOLOGOUS CULTURED
CHONDROCYTES: ADVERSE EVENTS REPORTED TO THE UNITED STATES
FOOD AND DRUG ADMINISTRATION JBJS 88

[7]

Lin Z, Fitzgerald J B, Xu J, Willers C, Wood D, Grodzinsky A J and Zheng M H 2008
Gene expression profiles of human chondrocytes during passaged monolayer
cultivation J. Orthop. Res. 26 1230–7

[8]

Dewan A K, Gibson M A, Elisseeff J H and Trice M E 2014 Evolution of Autologous
Chondrocyte Repair and Comparison to Other Cartilage Repair Techniques 2014

[9]

Deng Z, Jin J, Zhao J and Xu H 2016 Cartilage defect treatments: With or without
cells? Mesenchymal stem cells or chondrocytes? Traditional or matrix-assisted? A
systematic review and meta-analyses Stem Cells Int. 2016

[10]

Goldring M B and Goldring S R 2010 Articular cartilage and subchondral bone in the
pathogenesis of osteoarthritis Ann. N. Y. Acad. Sci. 1192 230–7

[11]

Omori G 2005 Epidemiology of knee osteoarthritis Acta Med. Biol. (Niigata). 53 1–11

[12]

Vos T, Flaxman A D, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K,
Salomon J A, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn S Y,
35

Ali M K, Alvarado M, Anderson H R, Anderson L M, Andrews K G, Atkinson C,
Baddour L M, Bahalim A N, Barker-Collo S, Barrero L H, Bartels D H, Basáñez M G,
Baxter A, Bell M L, Benjamin E J, Bennett D, Bernabé E, Bhalla K, Bhandari B,
Bikbov B, Abdulhak A Bin, Birbeck G, Black J A, Blencowe H, Blore J D, Blyth F,
Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T,
Brayne C, Bridgett L, Brooker S, Brooks P, Brugha T S, Bryan-Hancock C, Bucello C,
Buchbinder R, Buckle G, Budke C M, Burch M, Burney P, Burstein R, Calabria B,
Campbell B, Canter C E, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F,
Chen H, Cheng A T A, Chou D, Chugh S S, Coffeng L E, Colan S D, Colquhoun S,
Colson K E, Condon J, Connor M D, Cooper L T, Corriere M, Cortinovis M, De
Vaccaro K C, Couser W, Cowie B C, Criqui M H, Cross M, Dabhadkar K C, Dahiya
M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L,
Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais D C, et al 2012 Years
lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010:
A systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163–
96
[13]

Ondrésik M, Azevedo Maia F R, da Silva Morais A, Gertrudes A C, Dias Bacelar A
H, Correia C, Gonçalves C, Radhouani H, Amandi Sousa R, Oliveira J M and Reis R L
2017 Management of knee osteoarthritis. Current status and future trends Biotechnol.
Bioeng. 114 717–39

[14]

Baugé C and Boumédiene K 2015 Use of Adult Stem Cells for Cartilage Tissue
Engineering: Current Status and Future Developments Stem Cells Int. 2015

[15]

Martin I, Ireland H, Baldomero H and Passweg J 2015 The Survey on Cellular and
Engineered Tissue Therapies in Europe in 2012* Tissue Eng. Part A 21 1–13

[16]

Cornelissen D-J, Faulkner-Jones A and Shu W 2017 Current developments in 3D
bioprinting for tissue engineering Curr. Opin. Biomed. Eng. 2 76–82

[17]

Liu Y, Zhou G and Cao Y 2017 Recent Progress in Cartilage Tissue Engineering—
Our Experience and Future Directions Engineering 3 28–35

[18]

Daly A C, Freeman F E, Gonzalez-Fernandez T, Critchley S E, Nulty J and Kelly D J
2017 3D Bioprinting for Cartilage and Osteochondral Tissue Engineering Adv.
Healthc. Mater. 6 1–20
36

[19]

Di Bella C, Fosang A, Donati D M, Wallace G G and Choong P F M 2015 3D
Bioprinting of Cartilage for Orthopedic Surgeons: Reading between the Lines Front.
Surg. 2 1–7

[20]

Iwasa J, Engebretsen L, Shima Y and Ochi M 2009 Clinical application of scaffolds
for cartilage tissue engineering Knee Surgery, Sport. Traumatol. Arthrosc. 17 561–77

[21]

Kang H-W, Yoo J J and Atala A 2015 Bioprinted Scaffolds for Cartilage Tissue
Engineering BT - Cartilage Tissue Engineering: Methods and Protocols ed P M Doran
(New York, NY: Springer New York) pp 161–9

[22]

Rai V, Dilisio M F, Dietz N E and Agrawal D K 2017 Recent strategies in cartilage
repair: A systemic review of the scaffold development and tissue engineering J.
Biomed. Mater. Res. Part A 105 2343–54

[23]

Koh J L, Wirsing K, Lautenschlager E and Zhang L-O 2004 The Effect of Graft
Height Mismatch on Contact Pressure following Osteochondral Grafting: A
Biomechanical Study Am. J. Sports Med. 32 317–20

[24]

Mollon B, Kandel R, Chahal J and Theodoropoulos J 2013 The clinical status of
cartilage tissue regeneration in humans Osteoarthr. Cartil. 21 1824–33

[25]

Keriquel V, Guillemot F, Arnault I, Guillotin B, Miraux S, Amédée J, Fricain J-C and
Catros S 2010 In vivo bioprinting for computer- and robotic-assisted medical
intervention: preliminary study in mice. Biofabrication 2 014101

[26]

Ozbolat I T 2018 Bioprinting scale-up tissue and organ constructs for transplantation
Trends Biotechnol. 33 395–400

[27]

Schmutzer M and Aszodi A 2017 Cell compaction influences the regenerative
potential of passaged bovine articular chondrocytes in an ex vivo cartilage defect
model J. Biosci. Bioeng. 123 512–22

[28]

Bartz C, Meixner M, Giesemann P, Roël G, Bulwin G-C and Smink J J 2016 An ex
vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant
J. Transl. Med. 14 317

[29]

O’Connell C D, Di Bella C, Thompson F, Augustine C, Beirne S, Cornock R,
Richards C J, Chung J, Gambhir S, Yue Z, Bourke J, Zhang B, Taylor A, Quigley A,
Kapsa R, Choong P and Wallace G G 2016 Development of the Biopen: a handheld
37

device for surgical printing of adipose stem cells at a chondral wound site.
Biofabrication 8 015019
[30]

Di Bella C, Duchi S, O’Connell C D, Blanchard R, Augustine C, Yue Z, Thompson F,
Richards C, Beirne S, Onofrillo C, Bauquier S H, Ryan S D, Pivonka P, Wallace G G
and Choong P F In situ handheld three-dimensional bioprinting for cartilage
regeneration J. Tissue Eng. Regen. Med. n/a-n/a

[31]

Duchi S, Onofrillo C, O’Connell C D, Blanchard R, Augustine C, Quigley A F, Kapsa
R M I, Pivonka P, Wallace G, Di Bella C and Choong P F M 2017 Handheld Co-Axial
Bioprinting: Application to in situ surgical cartilage repair Sci. Rep. 7 1–12

[32]

Moyad T F 2011 Cartilage injuries in the adult knee: Evaluation and management
Cartilage 2 226–36

[33]

Ye K, Felimban R, Traianedes K, Moulton S E, Wallace G G, Chung J, Quigley A,
Choong P F M and Myers D E 2014 Chondrogenesis of infrapatellar fat pad derived
adipose stem cells in 3D printed chitosan scaffold PLoS One 9

[34]

Estes B T, Diekman B O, Gimble J M and Guilak F 2010 Isolation of adipose-derived
stem cells and their induction to a chondrogenic phenotype Nat. Protoc. 5 1294–311

[35]

Felimban R, Ye K, Traianedes K, Di Bella C, Crook J, Wallace G G, Quigley A,
Choong P F M and Myers D E 2014 Differentiation of Stem Cells from Human
Infrapatellar Fat Pad: Characterization of Cells Undergoing Chondrogenesis. Tissue
Eng. Part A 00 1–11

[36]

Lucarelli E, Bellotti C, Mantelli M, Avanzini M A, Maccario R, Novara F, Arrigo G,
Zuffardi O, Zuntini M, Pandolfi M, Sangiorgi L, Lisini D, Donati D and Duchi S 2014
In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived
from the bone marrow of sarcoma patients. J. Transl. Med. 12 95

[37]

Loessner D, Meinert C, Kaemmerer E, Martine L C, Yue K, Levett P A, Klein T J,
Melchels F P W, Khademhosseini A and Hutmacher D W 2016 Functionalization,
preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular
tissue culture platforms Nat. Protoc. 11 727–46

[38]

Knudson C B 2003 Hyaluronan and CD44: Strategic players for cell–matrix
interactions during chondrogenesis and matrix assembly Birth Defects Res. Part C
38

Embryo Today Rev. 69 174–96
[39]

Barry F and Murphy M 2013 Mesenchymal stem cells in joint disease and repair Nat
Rev Rheumatol 9 584–94

[40]

Du D, Sugita N, Liu Z, Moriguchi Y, Nakata K, Myoui A and Yoshikawa H 2015
Repairing osteochondral defects of critical size using multiple costal grafts: An
experimental study Cartilage 6 241–51

[41]

Katagiri H, Mendes L F and Luyten F P 2017 Definition of a Critical Size
Osteochondral Knee Defect and its Negative Effect on the Surrounding Articular
Cartilage in the Rat Osteoarthr. Cartil. 25 1531–40

[42]

Squitieri L. 2005 Method for quantitative analysis of glycosaminoglycans and type II
collagen in chondrocyte-seeded articular cartilage scaffolds with varied cross-linking
density. http://dspace.mit.edu/handle/1721.1/32924

[43]

Bi W, Deng J M, Zhang Z, Behringer R R and de Crombrugghe B 1999 Sox9 is
required for cartilage formation Nat. Genet. 22 85

[44]

Bi W, Huang W, Whitworth D J, Deng J M, Zhang Z, Behringer R R and de
Crombrugghe B 2001 Haploinsufficiency of Sox9 results in defective cartilage
primordia and premature skeletal mineralization Proc. Natl. Acad. Sci. U. S. A. 98
6698–703

[45]

Marlovits S, Hombauer M, Truppe M, Vècsei V and Schlegel W 2004 Changes in the
ratio of type-I and type-II collagen expression during monolayer culture of human
chondrocytes Bone Joint J. 86–B 286–95

[46]

Kelly A C D and S E C and E M R and D J 2016 A comparison of different bioinks
for 3D bioprinting of fibrocartilage and hyaline cartilage Biofabrication 8 45002

[47]

Gregory Yourek, Mohammad A. Hussai† and J J M 2014 Cytoskeletal Changes of
Mesenchymal Stem Cells During Differentiation 53 219–28

[48]

Shimizu H, Yokoyama S and Asahara H 2007 Growth and differentiation of the
developing limb bud from the perspective of chondrogenesis Dev. Growth Differ. 49
449–54

[49]

Olsen B R, Reginato A M and Wang W 2000 Bone Development Annu. Rev. Cell
39

Dev. Biol. 16 191–220
[50]

Wang M, Yuan Z, Ma N, Hao C, Guo W, Zou G, Zhang Y, Chen M, Gao S, Peng J,
Wang A, Wang Y, Sui X, Xu W, Lu S, Liu S and Guo Q 2017 Advances and Prospects
in Stem Cells for Cartilage Regeneration Stem Cells Int. 2017

[51]

Savkovic V, Li H, Seon J-K, Hacker M and Simon S F and J-C 2014 Mesenchymal
Stem Cells in Cartilage Regeneration Curr. Stem Cell Res. Ther. 9 469–88

[52]

Lee W Y and Wang B 2017 Cartilage repair by mesenchymal stem cells: Clinical trial
update and perspectives J. Orthop. Transl. 9 76–88

[53]

do Amaral R J F C, Almeida H V, Kelly D J, O’Brien F J and Kearney C J 2017
Infrapatellar Fat Pad Stem Cells: From Developmental Biology to Cell Therapy Stem
Cells Int. 2017 1–10

[54]

Knudson C B 2003 Hyaluronan and CD44: Strategic players for cell–matrix
interactions during chondrogenesis and matrix assembly Birth Defects Res. Part C
Embryo Today Rev. 69 174–96

[55]

Sawitzke A D 2013 Personalized medicine for osteoarthritis: where are we now? Ther.
Adv. Musculoskelet. Dis. 5 67–75

[56]

Gao Q, He Y, Fu J, Liu A and Ma L 2015 Coaxial nozzle-assisted 3D bioprinting with
built-in microchannels for nutrients delivery Biomaterials 61 203–15

[57]

Colosi C, Shin S R, Manoharan V, Massa S, Costantini M, Barbetta A, Dokmeci M R,
Dentini M and Khademhosseini A 2016 Microfluidic Bioprinting of Heterogeneous 3D
Tissue Constructs Using Low-Viscosity Bioink Adv. Mater. 28 677–84

[58]

Święszkowski M C and J I and K S and J J and M D and A B and J E B and W 2016
3D bioprinting of BM-MSCs-loaded ECM biomimetic hydrogels for in vitro
neocartilage formation Biofabrication 8 35002

[59]

Suryo Rahmanto A, Savov V, Brunner A, Bolin S, Weishaupt H, Malyukova A,
Rosén G, Čančer M, Hutter S, Sundström A, Kawauchi D, Jones D T W, Spruck C,
Taylor M D, Cho Y, Pfister S M, Kool M, Korshunov A, Swartling F J and Sangfelt O
2016 FBW7 suppression leads to SOX9 stabilization and increased malignancy in
medulloblastoma EMBO J. 35 2192–212

40

[60]

Hong X, Liu W, Song R, Shah J J, Feng X, Tsang C K, Morgan K M, Bunting S F,
Inuzuka H, Zheng X F S, Shen Z, Sabaawy H E, Liu L and Pine S R 2016 SOX9 is
targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA
damage Nucleic Acids Res. 44 8855–69

[61]

Hattori T, Kishino T, Stephen S, Eberspaecher H, Maki S, Takigawa M, de
Crombrugghe B and Yasuda H 2013 E6-AP/UBE3A Protein Acts as a Ubiquitin
Ligase toward SOX9 Protein J. Biol. Chem. 288 35138–48

[62]

Coricor G and Serra R 2016 TGF-β regulates phosphorylation and stabilization of
Sox9 protein in chondrocytes through p38 and Smad dependent mechanisms Sci. Rep.
6 38616

[63]

Marlovits S, Hombauer M, Truppe M, Vècsei V and Schlegel W 2004 Changes in the
ratio of type-I and type-II collagen expression during monolayer culture of human
chondrocytes Bone Joint J. 86–B 286–95

[64]

Levato R, Webb W R, Otto I A, Mensinga A, Zhang Y, van Rijen M, van Weeren R,
Khan I M and Malda J 2017 The bio in the ink: cartilage regeneration with
bioprintable hydrogels and articular cartilage-derived progenitor cells Acta Biomater.
61 41–53

[65]

Schuurman W, Levett P A, Pot M W, van Weeren P R, Dhert W J A, Hutmacher D
W, Melchels F P W, Klein T J and Malda J 2013 Gelatin-Methacrylamide Hydrogels
as Potential Biomaterials for Fabrication of Tissue-Engineered Cartilage Constructs
Macromol. Biosci. 13 551–61

[66]

Zipfel W R, Williams R M and Webb W W 2003 Nonlinear magic: multiphoton
microscopy in the biosciences Nat. Biotechnol. 21 1369

[67]

Zoumi A, Lu X, Kassab G S and Tromberg B J 2004 Imaging Coronary Artery
Microstructure Using Second-Harmonic and Two-Photon Fluorescence Microscopy
Biophys. J. 87 2778–86

[68]

Pacifici M, Koyama E, Shibukawa Y, Wu C, Tamamura Y, Enomoto-Iwamoto M and
Iwamoto M 2006 Cellular and Molecular Mechanisms of Synovial Joint and Articular
Cartilage Formation Ann. N. Y. Acad. Sci. 1068 74–86

[69]

Kim I G, Ko J, Lee H R, Do S H and Park K 2016 Mesenchymal cells condensation41

inducible mesh scaffolds for cartilage tissue engineering Biomaterials 85 18–29
[70]

Suzuki S, Muneta T, Tsuji K, Ichinose S, Makino H, Umezawa A and Sekiya I 2012
Properties and usefulness of aggregates of synovial mesenchymal stem cells as a
source for cartilage regeneration Arthritis Res. Ther. 14 R136

[71]

Censi R and Matricardi A D and Pietro 2015 Bioactive Hydrogel Scaffolds Advances in Cartilage Regeneration Through Controlled Drug Delivery Curr. Pharm.
Des. 21 1545–55

[72]

El-Ayoubi R, DeGrandpré C, DiRaddo R, Yousefi A-M and Lavigne P 2009 Design
and Dynamic Culture of 3D-Scaffolds for Cartilage Tissue Engineering J. Biomater.
Appl. 25 429–44

[73]

Chung C, Beecham M, Mauck R L and Burdick J A 2009 The influence of
degradation characteristics of hyaluronic acid hydrogels on in vitro neocartilage
formation by mesenchymal stem cells Biomaterials 30 4287–96

[74]

Roberts Bs J J, Nicodemus G D, Greenwald E C and Bryant S J 2011 Degradation
Improves Tissue Formation in (Un)Loaded Chondrocyte-laden Hydrogels

[75]

Duan B, Hockaday L A, Kang K H and Butcher J T 2013 3D Bioprinting of
heterogeneous aortic valve conduits with alginate/gelatin hydrogels J. Biomed. Mater.
Res. Part A 101A 1255–64

[76]

Marrella A, Lagazzo A, Barberis F, Catelani T, Quarto R and Scaglione S 2017
Enhanced mechanical performances and bioactivity of cell laden-graphene
oxide/alginate hydrogels open new scenario for articular tissue engineering
applications Carbon N. Y. 115 608–16

[77]

Kim K, Yoon D M, Mikos A G and Kasper F K 2012 Harnessing Cell–Biomaterial
Interactions for Osteochondral Tissue Regeneration BT - Tissue Engineering III: Cell
- Surface Interactions for Tissue Culture ed C Kasper, F Witte and R Pörtner (Berlin,
Heidelberg: Springer Berlin Heidelberg) pp 67–104

[78]

Sarem M, Arya N, Heizmann M, Neffe A T, Barbero A, Gebauer T P, Martin I,
Lendlein A and Shastri V P 2018 Interplay between stiffness and degradation of
architectured gelatin hydrogels leads to differential modulation of chondrogenesis in
vitro and in vivo Acta Biomater. 69 83–94
42

43

